[go: up one dir, main page]

WO2002102848A3 - Nouvelles sequences d'acides nucleiques et d'acides amines - Google Patents

Nouvelles sequences d'acides nucleiques et d'acides amines Download PDF

Info

Publication number
WO2002102848A3
WO2002102848A3 PCT/IL2002/000491 IL0200491W WO02102848A3 WO 2002102848 A3 WO2002102848 A3 WO 2002102848A3 IL 0200491 W IL0200491 W IL 0200491W WO 02102848 A3 WO02102848 A3 WO 02102848A3
Authority
WO
WIPO (PCT)
Prior art keywords
acid sequences
sequences
amino acid
nucleic acid
vegf variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IL2002/000491
Other languages
English (en)
Other versions
WO2002102848A2 (fr
Inventor
Liat Mintz
Kinneret Savitzky
Sharon Engel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Compugen Ltd
Original Assignee
Compugen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compugen Ltd filed Critical Compugen Ltd
Priority to EP02741129A priority Critical patent/EP1417310A2/fr
Priority to AU2002314491A priority patent/AU2002314491A1/en
Publication of WO2002102848A2 publication Critical patent/WO2002102848A2/fr
Anticipated expiration legal-status Critical
Publication of WO2002102848A3 publication Critical patent/WO2002102848A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Nouvelles séquences d'acides nucléiques et d'acides aminés d'un nouveau variant du facteur de croissance endothéliale vasculaire (VEGF). La présente invention concerne encore des vecteurs d'expression et des cellules hôtes contenant ces séquences ainsi que des compositions pharmaceutiques et des méthodes de détection reposant sur l'utilisation desdites séquences.
PCT/IL2002/000491 2001-06-20 2002-06-20 Nouvelles sequences d'acides nucleiques et d'acides amines Ceased WO2002102848A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP02741129A EP1417310A2 (fr) 2001-06-20 2002-06-20 Nouvelles sequences d'acides nucleiques et d'acides amines
AU2002314491A AU2002314491A1 (en) 2001-06-20 2002-06-20 Nucleic acid and amino acid sequences of a vegf variant

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88450101A 2001-06-20 2001-06-20
US09/884,O5O 2001-06-20

Publications (2)

Publication Number Publication Date
WO2002102848A2 WO2002102848A2 (fr) 2002-12-27
WO2002102848A3 true WO2002102848A3 (fr) 2004-03-04

Family

ID=25384758

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2002/000491 Ceased WO2002102848A2 (fr) 2001-06-20 2002-06-20 Nouvelles sequences d'acides nucleiques et d'acides amines

Country Status (3)

Country Link
EP (1) EP1417310A2 (fr)
AU (1) AU2002314491A1 (fr)
WO (1) WO2002102848A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106349389B (zh) * 2015-07-21 2019-11-15 科济生物医药（上海）有限公司 肿瘤特异性抗egfr抗体及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11178593A (ja) * 1997-12-24 1999-07-06 Fujirebio Inc Ｖｅｇｆ１２１特異的モノクローナル抗体及び測定方法
WO1999040197A2 (fr) * 1998-02-06 1999-08-12 Collateral Therapeutics, Inc. Variants du facteur angiogenique de croissance cellulaire endotheliale vasculaire vegf

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11178593A (ja) * 1997-12-24 1999-07-06 Fujirebio Inc Ｖｅｇｆ１２１特異的モノクローナル抗体及び測定方法
WO1999040197A2 (fr) * 1998-02-06 1999-08-12 Collateral Therapeutics, Inc. Variants du facteur angiogenique de croissance cellulaire endotheliale vasculaire vegf

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EBI; 18 April 1997 (1997-04-18), XP002231091, Database accession no. AA350839 *
DATABASE EMBL [online] EBI; 7 January 2000 (2000-01-07), XP002231090, Database accession no. AL136131 *
NIELSEN H J ET AL: "Soluble vascular endothelial growth factor in various blood transfusion components.", TRANSFUSION (BETHESDA), vol. 39, no. 10, October 1999 (1999-10-01), pages 1078 - 1083, XP002231275, ISSN: 0041-1132 *
ONO KATSUAKI ET AL: "Structural features in heparin that interact with VEGF165 and modulate its biological activity.", GLYCOBIOLOGY, vol. 9, no. 7, July 1999 (1999-07-01), pages 705 - 711, XP009006033, ISSN: 0959-6658 *
PALEY PAMELA J ET AL: "Vascular endothelial growth factor expression in early stage ovarian carcinoma.", CANCER, vol. 80, no. 1, 1997, pages 98 - 106, XP002231274, ISSN: 0008-543X *
PATENT ABSTRACTS OF JAPAN vol. 1999, no. 12 29 October 1999 (1999-10-29) *
ROBINSON C J ET AL: "THE SPLICE VARIANTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND THEIR RECEPTORS", JOURNAL OF CELL SCIENCE, ESSEX, GB, vol. 114, no. PART 5, March 2001 (2001-03-01), pages 853 - 865, XP001105017 *

Also Published As

Publication number Publication date
EP1417310A2 (fr) 2004-05-12
WO2002102848A2 (fr) 2002-12-27
AU2002314491A1 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
WO2001075087A8 (fr) Variantes de lasubtilisine
WO2003052118A3 (fr) Beta-glucosidase bgl4 et acides nucleiques la codant
WO2003025154A3 (fr) Procedes et compositions pour la construction et l'utilisation de genotheques de fusion
WO1997033996A3 (fr) Bikunine humaine
WO2003011115A3 (fr) Agents de contraste multimères ciblés à base de peptides
AU2001261499A1 (en) Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins
WO2003012105A3 (fr) Isoforme de facteur de croissance
WO2005113592A3 (fr) Polypeptides et conjugues interferon-alpha
WO2004046365A3 (fr) Polypeptides et conjugues interferon-alpha
WO2003020932A1 (fr) Nouvelles proteines de secretion et adn associe
WO1999067382A3 (fr) Sequences d'un facteur de croissance apparente a l'angiopoietine
AU2003222717A1 (en) Streptavidin-binding peptide
WO2004087874A3 (fr) Acides nucleiques et polypeptides
WO2004007664A3 (fr) Vecteurs d'acides nucleiques
WO2002022826A3 (fr) Methodes et compositions de construction et d'utilisation de bibliotheques de fusion
AU2003304145A1 (en) Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia
WO2002036627A3 (fr) Interferons, utilisations et compositions associees
AU2002316586A1 (en) Novel dna polymerases having amino acid substitutions and homologs thereof
WO2001036632A3 (fr) Variants d'epissage alternatif
WO2003002730A3 (fr) Methode de detection de l'activite de la calpaine 3 dans un echantillon biologique et peptides pour la mise en oeuvre de ladite methode
WO2003006492A3 (fr) Peptides exerçant une activite biologique
AU2001278655A1 (en) Novel nucleic acid and amino acid sequences
WO2002102848A3 (fr) Nouvelles sequences d'acides nucleiques et d'acides amines
WO2001092493A3 (fr) Nouvelles aminopeptidases humaines 21956 et 25856, et utilisations
WO2000046391A3 (fr) Genes affichant une expression amelioree pendant une senescence cellulaire et une differentiation cellulaire terminale, et leurs utilisations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002741129

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002741129

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2002741129

Country of ref document: EP